Condition: ADHD · Depression Disorders · Mood Disorders · Sponsor: Gaize
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
This description comes directly from the study's public registry record.
Apurva Raje Research Coordinator / Principal Investigator, BA · 732-397-1795 · apurva.raje@gaize.ai
Rob Kaufmann CTO · rob.kaufmann@gaize.ai
Always discuss trial participation with your own doctor first.
| Gaize | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07389473